Jilin Jian Yisheng Pharmaceutical Co Ltd Net Asset Quality Index
Jilin Jian Yisheng Pharmaceutical Co Ltd net asset quality index. Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Net Asset Quality Index of 78.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.01 Billion minus total liabilities of CN¥660.73 Million yields net assets of CN¥2.35 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Net asset quality index of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025. This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 78.0%, representing net assets of CN¥2.35 Billion against total assets of CN¥3.01 Billion CNY. See 002566 net assets for net asset value and shareholders' equity analysis.
Jilin Jian Yisheng Pharmaceutical Co Ltd Net Asset Quality Index by Year (2006–2025)
Jilin Jian Yisheng Pharmaceutical Co Ltd net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Jilin Jian Yisheng Pharmaceutical Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.7% | CN¥2.33 Billion | CN¥2.96 Billion | CN¥630.35 Million | ▲ +0.2 pp |
| 2024 | 78.5% | CN¥2.33 Billion | CN¥2.97 Billion | CN¥637.22 Million | ▲ +2.0 pp |
| 2023 | 76.6% | CN¥2.33 Billion | CN¥3.05 Billion | CN¥714.30 Million | ▲ +0.7 pp |
| 2022 | 75.8% | CN¥2.25 Billion | CN¥2.97 Billion | CN¥717.18 Million | ▼ -0.9 pp |
| 2021 | 76.7% | CN¥2.20 Billion | CN¥2.86 Billion | CN¥666.08 Million | ▲ +0.5 pp |
| 2020 | 76.3% | CN¥2.13 Billion | CN¥2.80 Billion | CN¥663.86 Million | ▼ -6.2 pp |
| 2019 | 82.4% | CN¥2.06 Billion | CN¥2.50 Billion | CN¥438.66 Million | ▲ +5.4 pp |
| 2018 | 77.0% | CN¥1.97 Billion | CN¥2.55 Billion | CN¥587.49 Million | ▲ +5.5 pp |
| 2017 | 71.5% | CN¥1.90 Billion | CN¥2.65 Billion | CN¥756.40 Million | ▲ +4.1 pp |
| 2016 | 67.4% | CN¥1.80 Billion | CN¥2.67 Billion | CN¥869.67 Million | ▲ +1.2 pp |
| 2015 | 66.3% | CN¥1.75 Billion | CN¥2.63 Billion | CN¥888.65 Million | ▼ -4.1 pp |
| 2014 | 70.3% | CN¥1.75 Billion | CN¥2.49 Billion | CN¥739.24 Million | ▼ -18.4 pp |
| 2013 | 88.7% | CN¥1.68 Billion | CN¥1.89 Billion | CN¥213.79 Million | ▼ -6.9 pp |
| 2012 | 95.6% | CN¥1.59 Billion | CN¥1.66 Billion | CN¥72.81 Million | ▼ -0.3 pp |
| 2011 | 95.9% | CN¥1.51 Billion | CN¥1.58 Billion | CN¥64.52 Million | ▲ +26.1 pp |
| 2010 | 69.8% | CN¥359.40 Million | CN¥515.06 Million | CN¥155.66 Million | ▲ +4.1 pp |
| 2009 | 65.7% | CN¥280.99 Million | CN¥427.66 Million | CN¥146.67 Million | ▲ +2.4 pp |
| 2008 | 63.3% | CN¥219.89 Million | CN¥347.32 Million | CN¥127.43 Million | ▲ +3.1 pp |
| 2007 | 60.2% | CN¥205.59 Million | CN¥341.67 Million | CN¥136.08 Million | ▼ -10.4 pp |
| 2006 | 70.6% | CN¥238.69 Million | CN¥338.04 Million | CN¥99.35 Million | — |